<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.0 20040830//EN" "http://dtd.nlm.nih.gov/publishing/2.0/journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="2.0">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">ResProt</journal-id>
      <journal-id journal-id-type="nlm-ta">JMIR Res Protoc</journal-id>
      <journal-title>JMIR Research Protocols</journal-title>
      <issn pub-type="epub">1929-0748</issn>
      <publisher>
        <publisher-name>JMIR Publications</publisher-name>
        <publisher-loc>Toronto, Canada</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">v14i1e67841</article-id>
      <article-id pub-id-type="pmid">40779315</article-id>
      <article-id pub-id-type="doi">10.2196/67841</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Protocol</subject>
        </subj-group>
        <subj-group subj-group-type="article-type">
          <subject>Protocol</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Effectiveness and Cost-Effectiveness of Using a Social Robot in Residential Care for Individuals With Challenges in Daily Structure and Planning: Protocol for a Multiple-Baseline Single Case Trial and Health Economic Evaluation</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Sarvestan</surname>
            <given-names> Javad</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="reviewer">
          <name>
            <surname>Tan</surname>
            <given-names>Cheng Kian  </given-names>
          </name>
        </contrib>
        <contrib contrib-type="reviewer">
          <name>
            <surname>Muschol</surname>
            <given-names>Jennifer</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib id="contrib1" contrib-type="author" corresp="yes">
          <name name-style="western">
            <surname>van Dam</surname>
            <given-names>Kirstin N</given-names>
          </name>
          <degrees>MSc</degrees>
          <xref rid="aff1" ref-type="aff">1</xref>
          <address>
            <institution>Academy Het Dorp, Research &#38; Advisory on Technology in Long-term Care</institution>
            <addr-line>Kemperbergerweg 139e</addr-line>
            <addr-line>Arnhem, 6815 RP</addr-line>
            <country>The Netherlands</country>
            <phone>31 88 377 9999</phone>
            <email>kirstin.van.dam@academyhetdorp.nl</email>
          </address>
          <xref rid="aff2" ref-type="aff">2</xref>
          <ext-link ext-link-type="orcid">https://orcid.org/0000-0002-1550-7184</ext-link>
        </contrib>
        <contrib id="contrib2" contrib-type="author">
          <name name-style="western">
            <surname>Gielissen</surname>
            <given-names>Marieke F M</given-names>
          </name>
          <degrees>PhD</degrees>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="aff2" ref-type="aff">2</xref>
          <ext-link ext-link-type="orcid">https://orcid.org/0000-0002-9943-8197</ext-link>
        </contrib>
        <contrib id="contrib3" contrib-type="author">
          <name name-style="western">
            <surname>Siebelink</surname>
            <given-names>Nienke M</given-names>
          </name>
          <degrees>PhD</degrees>
          <xref rid="aff1" ref-type="aff">1</xref>
          <ext-link ext-link-type="orcid">https://orcid.org/0000-0003-4710-1071</ext-link>
        </contrib>
        <contrib id="contrib4" contrib-type="author">
          <name name-style="western">
            <surname>van Mastrigt</surname>
            <given-names>Ghislaine A P G</given-names>
          </name>
          <degrees>PhD</degrees>
          <xref rid="aff3" ref-type="aff">3</xref>
          <xref rid="aff4" ref-type="aff">4</xref>
          <xref rid="aff5" ref-type="aff">5</xref>
          <ext-link ext-link-type="orcid">https://orcid.org/0000-0001-8053-5512</ext-link>
        </contrib>
        <contrib id="contrib5" contrib-type="author">
          <name name-style="western">
            <surname>den Hollander</surname>
            <given-names>Wouter</given-names>
          </name>
          <degrees>PhD</degrees>
          <xref rid="aff6" ref-type="aff">6</xref>
          <ext-link ext-link-type="orcid">https://orcid.org/0000-0002-0061-9511</ext-link>
        </contrib>
        <contrib id="contrib6" contrib-type="author">
          <name name-style="western">
            <surname>Boon</surname>
            <given-names>Brigitte</given-names>
          </name>
          <degrees>PhD</degrees>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="aff2" ref-type="aff">2</xref>
          <xref rid="aff7" ref-type="aff">7</xref>
          <ext-link ext-link-type="orcid">https://orcid.org/0000-0001-9340-9304</ext-link>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <label>1</label>
        <institution>Academy Het Dorp, Research &#38; Advisory on Technology in Long-term Care</institution>
        <addr-line>Arnhem</addr-line>
        <country>The Netherlands</country>
      </aff>
      <aff id="aff2">
        <label>2</label>
        <institution>Tranzo</institution>
        <institution>Tilburg School of Social and Behavioral Sciences</institution>
        <institution>Tilburg University</institution>
        <addr-line>Tilburg</addr-line>
        <country>The Netherlands</country>
      </aff>
      <aff id="aff3">
        <label>3</label>
        <institution>Care and Public Health Research Institute (Research School CAPHRI)</institution>
        <institution>Maastricht University</institution>
        <addr-line>Maastricht</addr-line>
        <country>The Netherlands</country>
      </aff>
      <aff id="aff4">
        <label>4</label>
        <institution>Department of Health Services Research</institution>
        <institution>Maastricht University</institution>
        <addr-line>Maastricht</addr-line>
        <country>The Netherlands</country>
      </aff>
      <aff id="aff5">
        <label>5</label>
        <institution>Maastricht HETA</institution>
        <institution>Maastricht University</institution>
        <addr-line>Maastricht</addr-line>
        <country>The Netherlands</country>
      </aff>
      <aff id="aff6">
        <label>6</label>
        <institution>Trimbos Institute, Netherlands Institute of Mental Health and Addiction</institution>
        <addr-line>Utrecht</addr-line>
        <country>The Netherlands</country>
      </aff>
      <aff id="aff7">
        <label>7</label>
        <institution>Siza, Center for Long-term Care for People with Disabilities</institution>
        <addr-line>Arnhem</addr-line>
        <country>The Netherlands</country>
      </aff>
      <author-notes>
        <corresp>Corresponding Author: Kirstin N van Dam <email>kirstin.van.dam@academyhetdorp.nl</email></corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2025</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>8</day>
        <month>8</month>
        <year>2025</year>
      </pub-date>
      <volume>14</volume>
      <elocation-id>e67841</elocation-id>
      <history>
        <date date-type="received">
          <day>22</day>
          <month>10</month>
          <year>2024</year>
        </date>
        <date date-type="rev-request">
          <day>5</day>
          <month>2</month>
          <year>2025</year>
        </date>
        <date date-type="rev-recd">
          <day>19</day>
          <month>3</month>
          <year>2025</year>
        </date>
        <date date-type="accepted">
          <day>11</day>
          <month>6</month>
          <year>2025</year>
        </date>
      </history>
      <copyright-statement>©Kirstin N van Dam, Marieke F M Gielissen, Nienke M Siebelink, Ghislaine A P G van Mastrigt, Wouter den Hollander, Brigitte Boon. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 08.08.2025.</copyright-statement>
      <copyright-year>2025</copyright-year>
      <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/">
        <p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Research Protocols, is properly cited. The complete bibliographic information, a link to the original publication on https://www.researchprotocols.org, as well as this copyright and license information must be included.</p>
      </license>
      <self-uri xlink:href="https://www.researchprotocols.org/2025/1/e67841" xlink:type="simple"/>
      <abstract>
        <sec sec-type="background">
          <title>Background</title>
          <p>A substantial number of individuals in disability care experience challenges with daily structure and planning and require 24-7 support. The use of a social robot might decrease their need for support from care professionals, leading to improved well-being of individuals with disabilities and increased work engagement for care professionals.</p>
        </sec>
        <sec sec-type="objective">
          <title>Objective</title>
          <p>This paper presents the research protocol for an effectiveness study and a health economic evaluation from a societal perspective on the use of a social robot by individuals experiencing challenges with daily structure and planning who are living in long-term disability care facilities in the Netherlands.</p>
        </sec>
        <sec sec-type="methods">
          <title>Methods</title>
          <p>We will assess the effectiveness of social robot care in reducing the level of support provided by care professionals in a multiple-baseline single case study. In total, 30 participants will be randomly allocated to 1 of 4 clusters, determining the baseline length (2, 3, 4, or 5 weeks) of a 13-week study period, and a 2-week follow-up will be conducted 6 months after participants start using the robot. During baseline, participants will receive care as usual. After baseline, participants will use the robot as part of their care plan. For each participant, 3 to 5 personal goals will be formulated, and attainment of these goals will be evaluated weekly. A health economic evaluation from a societal perspective will be performed to assess the cost-effectiveness.</p>
        </sec>
        <sec sec-type="results">
          <title>Results</title>
          <p>This study was funded in July 2023. As of October 2024, we enrolled 29 participants. Data collection is planned to be finished in the third quarter of 2025. Data analysis will be performed from the second quarter of 2025. Results will be published in peer-reviewed journals and presented at international conferences in 2026.</p>
        </sec>
        <sec sec-type="conclusions">
          <title>Conclusions</title>
          <p>We will provide insights into the effectiveness and cost-effectiveness of social robot care for individuals living in Dutch residential care facilities, aimed at enabling them to live more independently, reducing pressure on Dutch care professionals in times of growing staff shortages in long-term care, and allowing care facilities to make informed decisions about implementing such a technology.</p>
        </sec>
        <sec sec-type="registered-report">
          <title>International Registered Report Identifier (IRRID)</title>
          <p>DERR1-10.2196/67841</p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>assistive technology</kwd>
        <kwd>social robot</kwd>
        <kwd>executive dysfunction</kwd>
        <kwd>independence</kwd>
        <kwd>effectiveness</kwd>
        <kwd>health economic evaluation</kwd>
        <kwd>cost of illness</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="introduction">
      <title>Introduction</title>
      <sec>
        <title>Background</title>
        <p>In residential disability care, clients (from here on referred to as individuals) rely on care professionals for lifelong support and care. Many of them experience difficulties in facing the complex challenges of daily life, such as managing time, overseeing household tasks, or remembering important information. These challenges are often linked to executive dysfunctions, also known as higher-level cognitive dysfunctions (eg, planning, performing goal-directed tasks, procrastination, attention, taking initiative, and limited time management) [<xref ref-type="bibr" rid="ref1">1</xref>]. Such dysfunctions are common for individuals with neurodevelopmental disorders (eg, autism spectrum disorder), brain injuries (eg, acquired brain injury), or intellectual disabilities [<xref ref-type="bibr" rid="ref2">2</xref>,<xref ref-type="bibr" rid="ref3">3</xref>]. Therefore, these individuals need support in regaining daily structure. In the Netherlands, the size of this group was estimated to be 2 million people in 2024, based on estimates from various publications [<xref ref-type="bibr" rid="ref4">4</xref>-<xref ref-type="bibr" rid="ref6">6</xref>]. Approximately 84,000 of them live in a long-term care facility where they receive residential care [<xref ref-type="bibr" rid="ref7">7</xref>]. Care professionals provide essential support by offering reminders, answering questions, motivating task initiation, giving hints as to where to begin, and engaging in activities together. The individuals are dependent on this external support and may struggle to live independently and participate in everyday life, which in turn impacts their emotional well-being and overall quality of life [<xref ref-type="bibr" rid="ref8">8</xref>].</p>
        <p>Assistive technology holds great potential to offer support to individuals experiencing problems with daily structure and planning in their daily functioning [<xref ref-type="bibr" rid="ref2">2</xref>]. It may compensate for the gap between a person’s capacity and their everyday life challenges [<xref ref-type="bibr" rid="ref9">9</xref>], thereby decreasing a person’s dependence on the support of others [<xref ref-type="bibr" rid="ref10">10</xref>-<xref ref-type="bibr" rid="ref12">12</xref>]. Moreover, assistive technology offers opportunities to tailor the support to the person’s exact needs, particularly in situations where support provided by care professionals may be limited, insufficient, or unwanted. Systematic review of the literature shows that technology offering functions such as calendars and reminder alarms can improve memory and execution of tasks [<xref ref-type="bibr" rid="ref13">13</xref>]. However, Brandt et al [<xref ref-type="bibr" rid="ref13">13</xref>] conclude that further research on the effectiveness and cost-effectiveness of such technologies is warranted. In line with this, the Dutch Ministry of Health, Welfare, and Sport has emphasized the importance of evaluating the impact of innovative technologies in disability care settings to ensure that they are both effective and financially sustainable [<xref ref-type="bibr" rid="ref14">14</xref>]. Effectiveness studies measure the level of beneficial effect of interventions in “real-world” settings [<xref ref-type="bibr" rid="ref15">15</xref>,<xref ref-type="bibr" rid="ref16">16</xref>]. An explorative study [<xref ref-type="bibr" rid="ref17">17</xref>] found that a social robot that speaks out verbal instructions and reminders at a preset time can support individuals with acquired brain injury, autism spectrum disorder, and mild intellectual disability in remembering and executing daily tasks more independently. This social robot is already widely used in residential care in the Netherlands, particularly in older adult care. In addition, 28 Dutch disability care organizations have reported using this robot in a recent survey of used technology in Dutch long-term disability care [<xref ref-type="bibr" rid="ref18">18</xref>]. However, both the effectiveness and cost-effectiveness of using a social robot in care are still unknown.</p>
      </sec>
      <sec>
        <title>Aims</title>
        <p>We aim to evaluate the effectiveness and cost-effectiveness of using a social robot in Dutch residential disability care for individuals experiencing challenges with daily structure and planning.</p>
        <p>We will compare care involving a social robot (CiSR) to care as usual (CAU). The study consists of 2 parts, each with its own focus and research questions (RQs; <xref ref-type="boxed-text" rid="box1">Textbox 1</xref>).</p>
        <boxed-text id="box1" position="float">
          <title>Research questions (RQs).</title>
          <p>
            <bold>Effectiveness study</bold>
          </p>
          <p>RQ1: What is the effectiveness of compare care involving a social robot (CiSR) on the support provided by professional caregivers (frequency or duration) compared to care as usual (CAU)?</p>
          <p>RQ2: Does the potential effectiveness of CiSR persist at follow-up?</p>
          <p>RQ3: Which individual goals are set to be achieved by CiSR, and are these goals attained?</p>
          <p>RQ4: What is the effectiveness of CiSR on the well-being of individuals with challenges in daily structure and planning?</p>
          <p>RQ5: How does CiSR affect the work engagement of care professionals?</p>
          <p>
            <bold>Economic evaluation</bold>
          </p>
          <p>RQ6: What is the cost-effectiveness of CiSR, assessed by a model-based economic evaluation?</p>
        </boxed-text>
      </sec>
    </sec>
    <sec sec-type="methods">
      <title>Methods</title>
      <p>This paper presents the research protocol according to the SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials) guideline [<xref ref-type="bibr" rid="ref19">19</xref>].</p>
      <sec>
        <title>Study Design</title>
        <p>A multiple baseline single case study will be conducted in everyday care practice. Multiple baseline single case studies are based on the principle that evidence of a causal effect can be strengthened by assigning participants to baselines of varying lengths. The staggered introduction of the intervention helps to rule out alternative explanations such as maturation or testing and session experience [<xref ref-type="bibr" rid="ref20">20</xref>].</p>
        <p>The study period consists of 3 phases (within 13 weeks) and a follow-up phase (<xref rid="figure1" ref-type="fig">Figure 1</xref>, <xref ref-type="boxed-text" rid="box2">Textbox 2</xref>, and <xref ref-type="table" rid="table1">Table 1</xref>). The number and timing of clusters is based on power calculations while considering the practical feasibility. The intervention does not allow for blinding within the trial.</p>
        <fig id="figure1" position="float">
          <label>Figure 1</label>
          <caption>
            <p>Study planning overview. CAU: care as usual; CiSR: care involving a social robot.</p>
          </caption>
          <graphic xlink:href="resprot_v14i1e67841_fig1.png" alt-version="no" mimetype="image" position="float" xlink:type="simple"/>
        </fig>
        <boxed-text id="box2" position="float">
          <title>Summary of the study period.</title>
          <list list-type="bullet">
            <list-item>
              <p>Baseline phase: participants will be randomly allocated to 1 of 4 baseline lengths (2, 3, 4, and 5 weeks, respectively), resulting in 4 different clusters. In the baseline phase, participants will receive care as usual.</p>
            </list-item>
            <list-item>
              <p>Intervention adjustment phase: a 6-week phase in which each participant starts to receive compare care involving a social robot (CiSR), that is, using and adjusting to the social robot.</p>
            </list-item>
            <list-item>
              <p>Effect measurement phase: this period varies in length based on the cluster to which the participant is assigned, from 2 to 5 weeks. Participants will continue CiSR.</p>
            </list-item>
            <list-item>
              <p>Follow-up phase: to observe whether the results are maintained while participants continue CiSR, a follow-up measurement will take place 6 months after the start of the intervention adjustment phase.</p>
            </list-item>
          </list>
        </boxed-text>
        <table-wrap position="float" id="table1">
          <label>Table 1</label>
          <caption>
            <p>Study planning.</p>
          </caption>
          <table width="1000" cellpadding="5" cellspacing="0" border="1" rules="groups" frame="hsides">
            <col width="170"/>
            <col width="220"/>
            <col width="200"/>
            <col width="210"/>
            <col width="200"/>
            <col width="0"/>
            <thead>
              <tr valign="top">
                <td>Cluster</td>
                <td>Baseline</td>
                <td>Intervention</td>
                <td>Effect</td>
                <td>Follow-up</td>
                <td>
                  <break/>
                </td>
              </tr>
            </thead>
            <tbody>
              <tr valign="top">
                <td>1</td>
                <td>2 weeks of CAU<sup>a</sup></td>
                <td>6 weeks of CiSR<sup>b</sup></td>
                <td>5 weeks of CiSR</td>
                <td colspan="2">Weeks 34-35</td>
              </tr>
              <tr valign="top">
                <td>2</td>
                <td>3 weeks of CAU</td>
                <td>6 weeks of CiSR</td>
                <td>4 weeks of CiSR</td>
                <td colspan="2">Weeks 35-36</td>
              </tr>
              <tr valign="top">
                <td>3</td>
                <td>4 weeks of CAU</td>
                <td>6 weeks of CiSR</td>
                <td>3 weeks of CiSR</td>
                <td colspan="2">Weeks 36-37</td>
              </tr>
              <tr valign="top">
                <td>4</td>
                <td>5 weeks of CAU</td>
                <td>6 weeks of CiSR</td>
                <td>2 weeks of CiSR</td>
                <td colspan="2">Weeks 37-38</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="table1fn1">
              <p><sup>a</sup>CAU: care as usual.</p>
            </fn>
            <fn id="table1fn2">
              <p><sup>b</sup>CiSR: care involving a social robot.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec>
        <title>Ethical Considerations</title>
        <p>This study was approved by the Ethics Review Board Tilburg School of Social and Behavioral Sciences of Tilburg University (TSB_RP1461) and was exempted from ethics approval by the Medical Ethical Review Committee of Radboudumc, Nijmegen (2023-16798). Both the participants and care professionals will be provided with verbal and written information about the study, and their informed consent will be obtained before randomization. To promote full participation in the project, residential care organizations will receive a financial contribution for the research activities, up to a maximum amount of €10,000 (US $10.845,69; currency rate as per October 18, 2024) when different targets are met (such as enrolling 10 participants and completing data collection). Individuals participating in the study will receive no financial compensation. Pseudonymized data will be stored at a secure site with limited access and separated from personal data, such as names. The World Health Organization trial registration dataset is presented in <xref ref-type="supplementary-material" rid="app1">Multimedia Appendix 1</xref>.</p>
      </sec>
      <sec>
        <title>Recruitment</title>
        <sec>
          <title>Participants: Care Organizations</title>
          <p>Individuals with challenges in daily structure and planning will be recruited from 3 Dutch residential disability care organizations. Facilities will have to meet the criteria detailed in <xref ref-type="boxed-text" rid="box3">Textbox 3</xref>.</p>
          <boxed-text id="box3" position="float">
            <title>Inclusion criteria for care organizations.</title>
            <list list-type="bullet">
              <list-item>
                <p>Have an intention to sustainably implement the social robot</p>
              </list-item>
              <list-item>
                <p>Have an IT infrastructure to support the use of the social robot</p>
              </list-item>
              <list-item>
                <p>Show commitment to implementation and participation in the research, characterized by the following:</p>
                <list>
                  <list-item>
                    <p>release funding for the purchase of the social robot</p>
                  </list-item>
                  <list-item>
                    <p>provide human resources for implementation and training</p>
                  </list-item>
                  <list-item>
                    <p>provide a project leader to coordinate the project</p>
                  </list-item>
                </list>
              </list-item>
            </list>
          </boxed-text>
        </sec>
        <sec>
          <title>Participants: Individuals With Challenges in Daily Structure and Planning</title>
          <p>Individuals will be eligible for inclusion in the study if they meet the predefined inclusion and exclusion criteria, as detailed in <xref ref-type="boxed-text" rid="box4">Textbox 4</xref>.</p>
          <p>One coresearcher is recruited from each of the 3 participating care organizations. A coresearcher is an individual who receives care within the context of this care organization and can represent the perspective of the participants. The 3 coresearchers are each coupled with a researcher and will function as a duo. The duos will receive training on how to collaborate and perform coresearch. During the study, coresearch activities will be logged, and the impact of the coresearcher’s involvement on the participants will be evaluated.</p>
          <boxed-text id="box4" position="float">
            <title>Inclusion and exclusion criteria for individuals with challenges in daily structure and planning.</title>
            <p>
              <bold>Inclusion criteria</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p>Aged ≥18 years (no upper age limit)</p>
              </list-item>
              <list-item>
                <p>Currently receive residential care</p>
              </list-item>
              <list-item>
                <p>Struggle with daily structure and planning, for example, have trouble remembering appointments and activities, or require assistance to initiate them</p>
              </list-item>
              <list-item>
                <p>Capable of understanding and following verbal instructions</p>
              </list-item>
              <list-item>
                <p>Possess the cognitive capacity to set 3 to 5 personalized goals with the help of a care professional and are motivated to work on these goals with the support of the social robot; these are goals for which the participant usually receives daily or weekly support by a care professional at the start of the study</p>
              </list-item>
              <list-item>
                <p>Supported by motivated care professionals to guide them in using the social robot</p>
              </list-item>
            </list>
            <p>
              <bold>Exclusion criteria</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p>Prone to convert stress into physical aggressiveness</p>
              </list-item>
              <list-item>
                <p>Overly sensitive to stimuli</p>
              </list-item>
            </list>
          </boxed-text>
        </sec>
      </sec>
      <sec>
        <title>Procedure</title>
        <sec>
          <title>Overview</title>
          <p>The SEAR (Screened, Eligible, Approached, Randomized) framework [21 will be used to systematically monitor and report the recruitment of participnats, according to the CONSORT (Consolidated Standards of Reporting Trials) extension for N-of-1 flowchart [22.</p>
          <p>Eligible participants will receive an information letter about the study. The purpose of the research will be explained in a conversation and questions will be answered. The participant and care professional will be given sufficient time to consider the information. When they decide to participate in the study, participants will be asked to sign an informed consent form.</p>
        </sec>
        <sec>
          <title>Randomization</title>
          <p>The researcher (KNvD) will randomly assign each location within the participating care organizations to a cluster. Due to practical considerations, randomization will be applied at the location level rather than the participant level, as this ensures a consistent and manageable implementation for the care team. This cluster determines the duration of the baseline length (2, 3, 4, or 5 weeks). The first 4 locations will be randomly assigned to one of the 4 clusters using a random sequence generator. Subsequent locations will be assigned to the cluster with the fewest participants at that moment. If multiple clusters have the same number of participants, a random sequence generator will be used to decide the assignment. The risk of unequal exposure to external influences is limited due to the initial randomization of the first 4 locations and the balanced allocation strategy of the following locations, which aims to maintain the balance between the clusters.</p>
        </sec>
        <sec>
          <title>Start of the Study Period</title>
          <p>Within each participating care organization, the research period for all locations will begin simultaneously.</p>
        </sec>
      </sec>
      <sec>
        <title>Intervention: CiSR</title>
        <sec>
          <title>Social Robot (Tessa)</title>
          <p>In this study, the social robot Tessa will be used to support the participants. Tessa was developed by Tinybots [<xref ref-type="bibr" rid="ref23">23</xref>] and was originally designed with and for people with dementia. Tessa is a small wooden egg or flowerpot-shaped robot with amber LED-lit eyes, simulating eye contact and responsiveness. Tessa needs a connection to the power network and the internet via WiFi, MiFi, or cable. The social robot helps support daily structure by providing reminders and suggestions for activities. Tessa does not engage in complex conversations but offers a friendly and predictable presence in the home. From a central location in the user’s home, with a default female voice, Tessa pronounces upcoming appointments or tasks from the user’s day program, with repeated reminders, if necessary. The content of these messages is programmed via a web app, that can be accessed from a smartphone, tablet, or PC, functioning like a simple digital calendar. The app allows users—whether the participant, a care professional, or a family member—to personalize messages, adapting the robot’s communication to the user’s preferences. In this study, the care professional decides on the contents, timing, and frequency of these messages in consultation with the participant. Tessa can either give a reminder or ask a question that can be answered by the user with “yes” or “no.” Depending on the participant’s response, the social robot responds with a preprogrammed message and may give an additional reminder for the task. For example, Tessa asking the user to take a shower in the morning could be programmed with the following message: “Good morning! Did you take a shower?” If the user replies with “yes,” Tessa’s response could be programmed as “Good job, champ!” and if the user answers “no,” Tessa’s reaction could be programmed as “Hop in the shower, and start your day fresh!” The yes or no answers are logged and can be viewed in the web app, enabling the care professional to check task completion without having to ask the client directly.</p>
          <p>Each participant will tailor the use of the social robot to their own goals. Before the start of the study, the type, frequency, and duration of support provided by the care professionals, specifically regarding daily structure and planning, will be assessed. In consultation with the care professional, 3 to 5 goals will be selected to work on with the support of the social robot. These can involve (1) activities of daily living (such as brushing teeth, shaving, drinking enough water, and getting up and going to bed on time); (2) household activities (such as doing the dishes, cleaning, changing the bed, and making a shopping list); and (3) planning (such as being ready for an appointment on time or being aware of the daily schedule).</p>
        </sec>
        <sec>
          <title>Evaluation of Selected Goals by Goal Attainment Scaling Method Once a Week</title>
          <p>The selected goals will be formulated using the goal attainment scaling (GAS) method [<xref ref-type="bibr" rid="ref24">24</xref>]. Setting goals to work on with the support of the social robot is considered an integral part of the intervention and will be evaluated weekly from the start of the intervention adjustment phase. The GAS method is an individualized evaluation method to evaluate the progress of treatment goals, with goals being set according to the SMART (specific, measurable, achievable, relevant, and time-bound) principles and evaluated on a 5-point scale. Therefore, even when the goals of the participants are not similar, the progress on these goals is scored in a similar way. The GAS method is a valid and reliable method [<xref ref-type="bibr" rid="ref25">25</xref>]. If the participants find it overwhelming to work on all goals simultaneously, a realistic, stepwise schedule will be created.</p>
        </sec>
        <sec>
          <title>Training of Care Professionals</title>
          <p>To integrate the social robot into the care process, care professionals need to be trained through a demonstration and guided practice in using the technology. This will be carried out during a training session, in which an implementation expert will install the social robot together with the care professional or the care team. After this, the care professional will introduce the social robot to the participant. Besides learning how to use the technology, care professionals will need to change their working routines, as the social robot will handle reminders that they previously provided. Thus, they will need to deimplement CAU for these specific goals. This will be discussed with the care professionals during weekly phone calls.</p>
          <p>The social robot will be integrated into the care process, with the research team monitoring its implementation by logging and resolving support requests related to Tessa. During weekly phone calls with the care professionals, a researcher will check whether they have encountered any prevailing problems and directly help to solve these problems (eg, technical problems, problems with programming the messages, and communication issues between the various parties involved).</p>
        </sec>
        <sec>
          <title>Components of CAU</title>
          <p>During the baseline phase, the participant will receive CAU from care professionals. The care for individuals with challenges in structure and daily planning usually consists of several components, as described in <xref ref-type="boxed-text" rid="box5">Textbox 5</xref>.</p>
          <boxed-text id="box5" position="float">
            <title>Components of usual care for individuals with challenges in structure and daily planning.</title>
            <list list-type="bullet">
              <list-item>
                <p>Visual aid: the care professional provides instructions on paper or in digital format</p>
              </list-item>
              <list-item>
                <p>Hints: the care professional provides verbal instructions before the participant performs an activity</p>
              </list-item>
              <list-item>
                <p>Supervision: the care professional checks and provides general instructions during or after the performance of an activity</p>
              </list-item>
              <list-item>
                <p>Verbal instructions: the participant performs an activity while the care professional instructs the participant on what to do</p>
              </list-item>
              <list-item>
                <p>Demonstration: the care professional shows how to perform the activity, which the participant then replicates</p>
              </list-item>
              <list-item>
                <p>Doing tasks together: the care professional provides physical assistance or takes over part of the activity, while the participant performs the rest</p>
              </list-item>
              <list-item>
                <p>Taking over: the care professional performs the entire activity on behalf of the participant, who is not required to be involved.</p>
              </list-item>
            </list>
          </boxed-text>
        </sec>
      </sec>
      <sec>
        <title>Measures</title>
        <p>The study uses mixed methods, yielding quantitative as well as qualitative data, to answer the RQs.</p>
        <sec>
          <title>Effectiveness Study</title>
          <sec>
            <title>Primary Outcome</title>
            <p>The primary outcome variable is the support provided by care professionals to the participant per week. These support moments will be registered daily in a “support diary” for each participant throughout the research period. Each day, the care professionals involved in the support of the participant will log the frequency and duration of each support moment provided to the participant during their shift. On the basis of the intake information provided by the care professionals, the diaries will be standardized and personalized by prefilling the typical daily prevalent types of support relevant to each participant. In this way, the caregivers only need to log frequency and duration of these predefined types of support and provide content descriptions only in cases of nonroutine support. To ensure consistency, the care professionals will receive detailed instructions on how to fill in the diaries by a standardized procedure, which includes participation of the researchers in team meetings and a “test week” before the study period to practice diary logging. Throughout the study, the researcher will hold weekly meetings with a designated care professional at each location to monitor compliance. In addition, to assess interrater reliability of the diary entries, on-site observations will be performed by the researchers.</p>
          </sec>
          <sec>
            <title>Secondary Outcomes</title>
          </sec>
        </sec>
        <sec>
          <title>Content of Support Provided by the Care Professionals</title>
          <p>The care professionals will log the content of the support they provided to the participants in the support diary. During weekly calls with the care professional, a researcher will also inquire whether there are changes in the content of the provided support and what these changes are.</p>
        </sec>
        <sec>
          <title>Well-Being of the Participants</title>
          <p>The Personal Wellbeing Index–Intellectual Disability will be used to measure well-being. The scale is designed specifically for individuals who have an intellectual disability or other form of cognitive impairment and is considered a state-of-the-art instrument to measure subjective well-being in this population with acceptable psychometric properties [<xref ref-type="bibr" rid="ref26">26</xref>]. It measures 8 domains of quality of life: life satisfaction, standard of living, health, life achievement, personal relationships, personal safety, community-connectedness, and future security. The Personal Wellbeing Index–Intellectual Disability will be administered 5 times (once every study phase; twice during the intervention adjustment phase).</p>
          <p>The 10-item version of the Psychosocial Impact of Assistive Device Scale-Adults measures the psychosocial impact of CiSR, on items such as happiness, independence, self-esteem, and sense of control [<xref ref-type="bibr" rid="ref27">27</xref>]. The systematic review performed by Atigossou et al [<xref ref-type="bibr" rid="ref27">27</xref>] supports the use of the 10-item version of the Psychosocial Impact of Assistive Device Scale-Adults and states that it has overall good psychometric properties.</p>
          <p>Both questionnaires will be filled in as part of an in-depth interview. During this interview, participants will also be asked about their experiences with the social robot and its added value, with questions such as “What do you find most helpful about Tessa?” or “What would you miss the most if Tessa would be no longer available to you?” The interviews will be guided by a specific topic list, which is available upon request from the corresponding author.</p>
        </sec>
        <sec>
          <title>Perception of Work by the Care Professionals</title>
          <p>To measure work engagement, the care professionals and involved care teams will be asked to complete a short questionnaire, consisting of eight 5-point Likert scale questions, such as “Working with the social robot brings me more enjoyment in my work” or “Working with the social robot helps me save time.”</p>
          <p>Complementary in-depth interviews with care professionals will be held to explore their experiences with the implementation of the social robot and how it affects their work engagement. In addition, care professionals will be asked about the perceived added value of CiSR for each client and how it influences the support provided to this participant, with questions such as “How do you perceive the impact of using Tessa on the participant’s progress toward their personal goal?” or “How do you incorporate the use of Tessa into the support you provide to the participant?” The interviews will be guided by a specific topic list, which is available upon request from the corresponding author.</p>
          <sec>
            <title>Economic Evaluation</title>
            <sec>
              <title>Medical Consumption and Productivity Cost</title>
              <p>Together with the intervention costs, such as the purchase of the social robot and subscription costs, medical consumption and productivity costs will be considered. To measure the medical consumption and productivity costs, a questionnaire containing relevant items from the iMTA Medical Cost Questionnaire and iMTA Assessment Productivity Cost Questionnaire will be conducted at baseline, effect, and follow-up [<xref ref-type="bibr" rid="ref28">28</xref>,<xref ref-type="bibr" rid="ref29">29</xref>]. These questionnaires are commonly used to study cost-effectiveness and can be adjusted by selecting relevant items.</p>
            </sec>
            <sec>
              <title>Quality of Life</title>
              <p>To measure the participants’ quality of life, the Icepop Capability Measure for Adults (ICECAP-A) will be administered [<xref ref-type="bibr" rid="ref30">30</xref>,<xref ref-type="bibr" rid="ref31">31</xref>]. The use of this questionnaire is advised when performing a cost-effectiveness study [<xref ref-type="bibr" rid="ref32">32</xref>]. The ICECAP-A contains 5 items measuring stability, attachment, autonomy, achievement, and enjoyment.</p>
              <p><xref ref-type="table" rid="table2">Table 2</xref> shows an overview of the measurements.</p>
              <table-wrap position="float" id="table2">
                <label>Table 2</label>
                <caption>
                  <p>Study measurements overview.</p>
                </caption>
                <table width="1000" cellpadding="5" cellspacing="0" border="1" rules="groups" frame="hsides">
                  <col width="350"/>
                  <col width="90"/>
                  <col width="180"/>
                  <col width="80"/>
                  <col width="130"/>
                  <col width="170"/>
                  <thead>
                    <tr valign="top">
                      <td>Measurement</td>
                      <td>Baseline</td>
                      <td>Intervention adjustment</td>
                      <td>Effect</td>
                      <td>Follow-up</td>
                      <td>Used to answer RQ<sup>a</sup></td>
                    </tr>
                  </thead>
                  <tbody>
                    <tr valign="top">
                      <td>Daily registration of support (diary)<sup>b</sup></td>
                      <td>✓</td>
                      <td>✓</td>
                      <td>✓</td>
                      <td>✓</td>
                      <td>RQ1 and RQ2</td>
                    </tr>
                    <tr valign="top">
                      <td>Weekly evaluation of goals (GAS<sup>c</sup>)<sup>b</sup></td>
                      <td>
                        <break/>
                      </td>
                      <td>✓</td>
                      <td>✓</td>
                      <td>✓</td>
                      <td>RQ3</td>
                    </tr>
                    <tr valign="top">
                      <td>Interview: well-being (PWI-ID<sup>d</sup>)<sup>b</sup></td>
                      <td>✓</td>
                      <td>✓</td>
                      <td>✓</td>
                      <td>✓</td>
                      <td>RQ4</td>
                    </tr>
                    <tr valign="top">
                      <td>Interview: psychosocial impact (PIADS-10<sup>e</sup>)<sup>f</sup></td>
                      <td>
                        <break/>
                      </td>
                      <td>
                        <break/>
                      </td>
                      <td>✓</td>
                      <td>✓</td>
                      <td>RQ4</td>
                    </tr>
                    <tr valign="top">
                      <td>Interview: added value of CiSR<sup>f,g</sup></td>
                      <td>
                        <break/>
                      </td>
                      <td>
                        <break/>
                      </td>
                      <td>✓</td>
                      <td>✓</td>
                      <td>RQ4</td>
                    </tr>
                    <tr valign="top">
                      <td>Interview: work engagement and added value of CiSR<sup>h</sup></td>
                      <td>
                        <break/>
                      </td>
                      <td>
                        <break/>
                      </td>
                      <td>✓</td>
                      <td>✓</td>
                      <td>RQ3, RQ4, and RQ5</td>
                    </tr>
                    <tr valign="top">
                      <td>Questionnaire: work engagement<sup>h</sup></td>
                      <td>
                        <break/>
                      </td>
                      <td>
                        <break/>
                      </td>
                      <td>✓</td>
                      <td>✓</td>
                      <td>RQ5</td>
                    </tr>
                    <tr valign="top">
                      <td>Questionnaire: medical consumption and productivity cost (iMCQ<sup>i</sup>+iPCQ<sup>j</sup>)<sup>b</sup></td>
                      <td>✓</td>
                      <td>
                        <break/>
                      </td>
                      <td>✓</td>
                      <td>✓</td>
                      <td>RQ6 and RQ7</td>
                    </tr>
                    <tr valign="top">
                      <td>Questionnaire: quality of life (ICECAP-A<sup>k</sup>)<sup>b</sup></td>
                      <td>✓</td>
                      <td>
                        <break/>
                      </td>
                      <td>✓</td>
                      <td>✓</td>
                      <td>RQ6 and RQ7</td>
                    </tr>
                  </tbody>
                </table>
                <table-wrap-foot>
                  <fn id="table2fn1">
                    <p><sup>a</sup>RQ: research question.</p>
                  </fn>
                  <fn id="table2fn2">
                    <p><sup>b</sup>Information on individuals with challenges in daily structure and planning, provided by the care professional.</p>
                  </fn>
                  <fn id="table2fn3">
                    <p><sup>c</sup>GAS: goal attainment scaling.</p>
                  </fn>
                  <fn id="table2fn4">
                    <p><sup>d</sup>PWI-ID: Personal Wellbeing Index–Intellectual Disability.</p>
                  </fn>
                  <fn id="table2fn5">
                    <p><sup>e</sup>PIADS-10: 10-item Psychosocial Impact of Assistive Devices Scale.</p>
                  </fn>
                  <fn id="table2fn6">
                    <p><sup>f</sup>Information on individuals with challenges in daily structure and planning provided by the individuals themselves.</p>
                  </fn>
                  <fn id="table2fn7">
                    <p><sup>g</sup>CiSR: care involving a social robot.</p>
                  </fn>
                  <fn id="table2fn8">
                    <p><sup>h</sup>Information on care professional.</p>
                  </fn>
                  <fn id="table2fn9">
                    <p><sup>i</sup>iMCQ: iMTA Assessment Medical Consumption Questionnaire.</p>
                  </fn>
                  <fn id="table2fn10">
                    <p><sup>j</sup>iPCQ: iMTA Assessment Productivity Cost Questionnaire.</p>
                  </fn>
                  <fn id="table2fn11">
                    <p><sup>k</sup>ICECAP-A: Icepop Capability Measure for Adults.</p>
                  </fn>
                </table-wrap-foot>
              </table-wrap>
            </sec>
          </sec>
          <sec>
            <title>Analysis</title>
            <sec>
              <title>Power</title>
              <p>Due to the staggered design, power was determined through simulation using the R (R Foundation for Statistical Computing) packages simstudy and lme [<xref ref-type="bibr" rid="ref33">33</xref>]. For a varying number of participants, 1000 datasets reflecting the staggered design were generated, all assuming a normally distributed outcome variable, a correlation between consecutive weeks of Pearson <italic>r</italic>=0.8, and a final effect of Cohen <italic>d</italic>=0.5 between the baseline phase and the first week of the effect phase (increasing linearly in 6 weeks). With 24 participants, a significant intervention effect (<italic>P</italic>&#60;.05) was observed in 80.3% (803/1000) of cases, between the measurements from the baseline phase and those from the effect phase. Assuming 22% dropout (based on the study by van Dam et al [<xref ref-type="bibr" rid="ref17">17</xref>]), the study is adequately powered when a total of 24 + (0.22 × 24) = 30 participants are included.</p>
            </sec>
          </sec>
          <sec>
            <title>Effectiveness Study</title>
            <p>Primary outcome data will be analyzed using a multilevel model (R, version 4.0+; package lme4) to investigate whether there is a significant difference between the level of professional care support moments (frequency or duration) per week in the baseline phase and the effect phase. The dependent continuous variable is the frequency and duration of professional care support moments per week. We will analyze all professional care support moments provided, as well as a selection of the specific professional care support moments connected to the goals for which the social robot is deployed.</p>
            <p>The independent binary variable is the moment of measurement (baseline phase or effect phase). Because there are multiple measurements per participant at both phases, the model will contain a random intercept for participants. Time will be included in the model as a covariate. Measurements are consequently averaged and compared within participants per phase. Following the intention-to-treat principle, all participants will be included in the analysis, regardless of whether the participant has used the social robot in all weeks during the intervention adjustment phase and effect phase. Because multilevel models handle missing values well, no imputation is needed [<xref ref-type="bibr" rid="ref34">34</xref>]. Quantitative secondary outcome data will be analyzed similarly. To assess the robustness of the primary outcome, additional per-protocol analyses and completers analyses will be performed as sensitivity analyses.</p>
            <p>Clinical relevance will be determined per participant. Here, two conditions must be met as follows: (1) a Reliable Change Index of &#62;1.96 for the level of support provided by care professionals [<xref ref-type="bibr" rid="ref35">35</xref>] and (2) with CiSR, the participant progresses in carrying out the selected activities independently (GAS score of ≥+1 for at least one goal).</p>
            <p>The follow-up data will be used to determine how many participants continue to receive CiSR, whether the effect is sustained in these participants, and what reasons there are to discontinue CiSR.</p>
            <p>As recommended by recent single-case intervention research design standards [<xref ref-type="bibr" rid="ref36">36</xref>], visual analysis will be conducted on the primary outcome. For each participant, data will be presented graphically to compare and interpret changes in patterns, level, and slope within and between different phases (baseline, intervention adjustment, effect, and follow-up). Using the contextual data collected for each case during the study period, we will qualitatively explore and report missing data patterns and discuss their implications for the robustness of the findings.</p>
            <p>Qualitative data will be coded and analyzed thematically using Atlas.ti (version 8.4.20; Lumivero, LLC).</p>
          </sec>
          <sec>
            <title>Health Economic Evaluation</title>
            <p>A model-based economic evaluation with a follow-up time equal to the life span of the social robot will be performed. This study will be reported by following the Consolidated Health Economic Evaluation Reporting Standards 2022 guidelines for reporting economic evaluations in health care [<xref ref-type="bibr" rid="ref37">37</xref>]. This study will also follow the Dutch guideline for health economic evaluations [<xref ref-type="bibr" rid="ref32">32</xref>].</p>
            <p>If the collected data suffices, the cost-effectiveness of CiSR will be examined by a model-based economic evaluation. For this, a Markov model, following the established guidelines [<xref ref-type="bibr" rid="ref32">32</xref>,<xref ref-type="bibr" rid="ref38">38</xref>], will be developed. Costs and effects will be modeled for 5 years with cycles of 3 months. The sources for transition opportunities, effects, and cost data will be the effect study, scientific literature, and expert opinions. Cost estimates from the Dutch costing manual will be used as a reference. For costs and health outcomes that occur after 1 year, a 3% discount rate to future costs and a 1.5% discount rate to future health outcomes will be applied [<xref ref-type="bibr" rid="ref32">32</xref>]. Cost prices will be expressed in euros based on the cost prices in 2024 (index year). If necessary, the existing cost prices will be updated to those in 2024 using the consumer price index available from Statistics Netherlands. Outcomes will be incremental cost-effectiveness ratios using societal costs and effects (the costs per reduced number of support moments), or incremental cost-utility ratios expressed in costs per quality-adjusted life years (QALYs). The QALYs will be calculated for the utilities obtained by the ICECAP-A [<xref ref-type="bibr" rid="ref39">39</xref>].</p>
            <p>For the analyses, R (version 4.0+; package lme4) will be used. Missing measurements will be handled using multiple imputations<italic>.</italic> Resource use and costs will be reported in means, SDs, and 95% CIs. Costs and outcomes will be measured at the baseline (CAU) and the effect and follow-up phases (CiSR). Baseline adjustments will be made if needed. Deterministic and probabilistic sensitivity analyses will be performed. Cost-effectiveness planes will be constructed by plotting the (bootstrapped) cost-effectiveness and cost-utility pairs. The likelihood that CiSR is a cost-effective option compared to CAU will be illustrated using a cost-effectiveness acceptability curve, which demonstrates the probability of an intervention being cost-effective for a given threshold. This represents the amount that society is willing to pay to gain one unit of effect. The willingness-to-pay threshold for the costs per reduced number of support moments is unknown, while the willingness-to-pay for a QALY varies across and within countries. In the Netherlands, the Health Council of the Netherlands estimated the QALY threshold between €20.000 and €80.000 (1=US $1.083; currency rate as per October 18, 2024) depending on the level of severity of the disease [<xref ref-type="bibr" rid="ref40">40</xref>].</p>
            <p>If, in practice, it appears that the data are of insufficient quality, making it impossible to create a model, the costs and effects will be described with a cost-consequence analysis.</p>
          </sec>
        </sec>
      </sec>
    </sec>
    <sec sec-type="results">
      <title>Results</title>
      <p>This project received approval for funding on July 13, 2023, by ZonMw, the Netherlands Organization for Health Research and Development (project 10310012210009). The funding period is 30 months.</p>
      <p>Data collection from 30 individuals living in residential disability care organizations and the care professionals who provide them support will yield insights into the effectiveness and cost-effectiveness of CiSR. By October 2024, we had enrolled 29 participants. Data collection is planned to be finished in the third quarter of 2025. Data analysis will be performed from the second quarter of 2025. Results will be published in peer-reviewed journals and presented at international conferences in 2026.</p>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <sec>
        <title>Expected Findings</title>
        <p>We expect to demonstrate that the sustainable and person-oriented implementation of a social robot in residential care for individuals with challenges in structure and daily planning will reduce the level of support provided by care professionals. As participants become more independent, the need for support is likely to decrease. This increased independence is anticipated to improve the well-being of participants and the work engagement of care professionals.</p>
        <p>In an era of increasing strain on care systems due to rising health care demands and staff shortages, the integration of technology holds substantial promise for improving quality of care. Technology enables more personalized care and might empower individuals to maintain independence in their daily routines, while reducing the need for constant human supervision and support. This may not only improve the quality of life for individuals but also allow care professionals to focus on more complex tasks and meaningful interactions with clients.</p>
        <p>Thorough research on the effects, added value, and costs will provide funding bodies and policy makers in long-term care organizations with the necessary information to make informed decisions about implementing technology such as the social robot used in this study. By leveraging these innovations, we can create a more sustainable, effective, and compassionate care system that meets the needs of both individuals and care professionals.</p>
      </sec>
      <sec>
        <title>Strengths and Limitations</title>
        <p>We describe the first adequately powered study that investigates the effectiveness and cost-effectiveness of using a social robot in daily residential care practice for individuals experiencing challenges with daily structure and planning. This study will give insight into the characteristics of participants for whom CiSR is successful by combining statistical and visual analysis and considering clinical relevance.</p>
        <p>Single-case experimental designs (SCEDs) are increasingly used in behavioral research and provide a clear framework for establishing causal relationships between interventions and outcomes. SCEDs are particularly useful in applied settings and allow researchers to conduct a thorough examination of an individual’s response to an intervention in their daily setting [<xref ref-type="bibr" rid="ref41">41</xref>]. While enabling analysis of data on a group level due to the multiple baseline design, the design of this study involves frequent measurements for each participant, providing valuable insights into individual effects as well. The use of 4 clusters enhances the internal validity by controlling for potential confounding variables [<xref ref-type="bibr" rid="ref42">42</xref>]. Given the large variation in support needs regarding daily structure and planning (nature, frequency, and severity) between participants, SCED enables a personalized approach essential to investigating the effectiveness of CiSR [<xref ref-type="bibr" rid="ref43">43</xref>]. Although personal goals are formulated for each participant, our multiple baseline SCED enables adequate comparison of results between individuals and the application of findings to daily care practice [<xref ref-type="bibr" rid="ref44">44</xref>]. While the results of group studies may not always apply to individuals, especially in the field of long-term care, SCED focuses on studying how individuals respond to an intervention. This can help understand how to apply the same intervention in the care and support for people with similar conditions [<xref ref-type="bibr" rid="ref45">45</xref>]. Therefore, with the use of SCED methodology —which allows for an in-depth analysis of individual responses and the identification of causal relationships— findings can be meaningfully interpreted beyond the specific setting [<xref ref-type="bibr" rid="ref46">46</xref>]. When compared to randomized clinical trials, SCEDs are often questioned for their lack of generalizability. In this study, generalizability is increased by 30 systematic replications (the same intervention, ie, CiSR, with different participants’ characteristics and settings) [<xref ref-type="bibr" rid="ref47">47</xref>]. This study takes place in a Dutch residential care context. However, given the use of SCED methodology, we anticipate that the findings will be transferable to individuals with similar challenges in residential care settings in other countries.</p>
        <p>This study will generate many data points, quantitatively by daily registrations by care professionals, and supported by qualitative data. Here, a potential limitation could be that care professionals might not be able to provide all the expected data due to their heavy workload. This could potentially lead to missing data points. To prevent missing data, we will invest in frequent personal contact with the care professionals involved and take early joint action to offer creative solutions in case of problems arising with the completion of the diaries.</p>
        <p>The reason for residential care locations to participate in this study is the desire to sustainably implement and use a social robot. To determine the effectiveness of CiSR, adequate implementation of the social robot in daily care practice by care professionals is essential. The research team will actively stimulate the actual adjustment of work processes to the use of the social robot by investing in weekly contact with the care professionals.</p>
        <p>Another strength of this study is the collaboration with coresearchers, which is expected to enable the collection of richer data and a better understanding of the participants and their settings [<xref ref-type="bibr" rid="ref48">48</xref>].</p>
        <p>Finally, this study includes longer-term follow-up assessments, enabling the examination of the sustainable use of the social robot as a part of daily care practice and the maintenance of its potential effects for individuals experiencing challenges with daily structure and planning.</p>
      </sec>
    </sec>
  </body>
  <back>
    <app-group>
      <supplementary-material id="app1">
        <label>Multimedia Appendix 1</label>
        <p>The World Health Organization trial registration dataset.</p>
        <media xlink:href="resprot_v14i1e67841_app1.docx" xlink:title="DOCX File , 22 KB"/>
      </supplementary-material>
    </app-group>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term id="abb1">CAU</term>
          <def>
            <p>care as usual</p>
          </def>
        </def-item>
        <def-item>
          <term id="abb2">CONSORT</term>
          <def>
            <p>Consolidated Standards of Reporting Trials</p>
          </def>
        </def-item>
        <def-item>
          <term id="abb3">CiSR</term>
          <def>
            <p>care involvinv a social robot</p>
          </def>
        </def-item>
        <def-item>
          <term id="abb4">GAS</term>
          <def>
            <p>goal attainment scaling</p>
          </def>
        </def-item>
        <def-item>
          <term id="abb5">ICECAP-A</term>
          <def>
            <p>Icepop Capability Measure for Adults</p>
          </def>
        </def-item>
        <def-item>
          <term id="abb6">QALY</term>
          <def>
            <p>quality-adjusted life year</p>
          </def>
        </def-item>
        <def-item>
          <term id="abb7">RQ</term>
          <def>
            <p>research question</p>
          </def>
        </def-item>
        <def-item>
          <term id="abb8">SCED</term>
          <def>
            <p>single-case experimental design</p>
          </def>
        </def-item>
        <def-item>
          <term id="abb9">SEAR</term>
          <def>
            <p>screened, eligible, approached, randomize</p>
          </def>
        </def-item>
        <def-item>
          <term id="abb10">SMART</term>
          <def>
            <p>specific, measurable, achievable, relevant, and time-bound</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <ack>
      <p>The authors would like to thank the care professionals and co-researchers who shared their expertise and provided valuable input in designing the support diary for this study. The authors thank Agnes van der Poel for her efforts in obtaining the research funding, Odile Smeets for her advice on the implementation strategy, Vivette van Cooten for her advice on the measuring instruments, and Patrick Onghena for his advice on the single-case experimental design methodology.</p>
      <p>This project is funded by ZonMw, the Netherlands Organization for Health Research and Development (project 10310012210009). This organization did not and will not have any role in the trial design, collection of data, analysis or interpretation of data, or the writing of the manuscript. The manufacturer of the social robot is not involved in this study.</p>
    </ack>
    <notes>
      <sec>
        <title>Data Availability</title>
        <p>The datasets generated or analyzed during this study will not be made publicly available due to the vulnerable position of the participants. However, they will be made available from the corresponding author upon reasonable request.</p>
      </sec>
    </notes>
    <fn-group>
      <fn fn-type="con">
        <p>KNvD and MFMG drafted the manuscript. KNvD was involved in finalizing the research instruments and will execute and manage the study under the supervision of MFMG and BB. NMS advised on the study design. GAPGvM advised on the economic evaluations. WdH contributed to the statistical analyses. BB, MFMG, GAPGvM, and WdH conceived the study design. All authors reviewed the manuscript for critical content and approved the final version.</p>
      </fn>
      <fn fn-type="conflict">
        <p>None declared.</p>
      </fn>
    </fn-group>
    <ref-list>
      <ref id="ref1">
        <label>1</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Rabinovici</surname>
              <given-names>GD</given-names>
            </name>
            <name name-style="western">
              <surname>Stephens</surname>
              <given-names>ML</given-names>
            </name>
            <name name-style="western">
              <surname>Possin</surname>
              <given-names>KL</given-names>
            </name>
          </person-group>
          <article-title>Executive dysfunction</article-title>
          <source>Continuum (Minneap Minn)</source>
          <year>2015</year>
          <month>06</month>
          <volume>21</volume>
          <issue>3 Behavioral Neurology and Neuropsychiatry</issue>
          <fpage>646</fpage>
          <lpage>59</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://europepmc.org/abstract/MED/26039846"/>
          </comment>
          <pub-id pub-id-type="doi">10.1212/01.CON.0000466658.05156.54</pub-id>
          <pub-id pub-id-type="medline">26039846</pub-id>
          <pub-id pub-id-type="pii">00132979-201506000-00011</pub-id>
          <pub-id pub-id-type="pmcid">PMC4455841</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref2">
        <label>2</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Spalla</surname>
              <given-names>G</given-names>
            </name>
            <name name-style="western">
              <surname>Yaddaden</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Kenfack Ngankam</surname>
              <given-names>H</given-names>
            </name>
            <name name-style="western">
              <surname>Gouin-Vallerand</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Bier</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Assistive technologies designed to support executive function impairments while promoting independence: a scoping review</article-title>
          <source>J Rehabil Assist Technol Eng</source>
          <year>2024</year>
          <month>08</month>
          <day>01</day>
          <volume>11</volume>
          <pub-id pub-id-type="doi">10.1177/20556683241268658</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref3">
        <label>3</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Spaniol</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Danielsson</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>A meta-analysis of the executive function components inhibition, shifting, and attention in intellectual disabilities</article-title>
          <source>J Intellect Disabil Res</source>
          <year>2022</year>
          <month>01</month>
          <volume>66</volume>
          <issue>1-2</issue>
          <fpage>9</fpage>
          <lpage>31</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="http://liu.diva-portal.org/smash/get/diva2:1600989/FULLTEXT01.pdf"/>
          </comment>
          <pub-id pub-id-type="doi">10.1111/jir.12878</pub-id>
          <pub-id pub-id-type="medline">34498787</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref4">
        <label>4</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Baxter</surname>
              <given-names>AJ</given-names>
            </name>
            <name name-style="western">
              <surname>Brugha</surname>
              <given-names>TS</given-names>
            </name>
            <name name-style="western">
              <surname>Erskine</surname>
              <given-names>HE</given-names>
            </name>
            <name name-style="western">
              <surname>Scheurer</surname>
              <given-names>RW</given-names>
            </name>
            <name name-style="western">
              <surname>Vos</surname>
              <given-names>T</given-names>
            </name>
            <name name-style="western">
              <surname>Scott</surname>
              <given-names>JG</given-names>
            </name>
          </person-group>
          <article-title>The epidemiology and global burden of autism spectrum disorders</article-title>
          <source>Psychol Med</source>
          <year>2015</year>
          <month>02</month>
          <volume>45</volume>
          <issue>3</issue>
          <fpage>601</fpage>
          <lpage>13</lpage>
          <pub-id pub-id-type="doi">10.1017/S003329171400172X</pub-id>
          <pub-id pub-id-type="medline">25108395</pub-id>
          <pub-id pub-id-type="pii">S003329171400172X</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref5">
        <label>5</label>
        <nlm-citation citation-type="web">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Woittiez</surname>
              <given-names>I</given-names>
            </name>
            <name name-style="western">
              <surname>Eggink</surname>
              <given-names>E</given-names>
            </name>
            <name name-style="western">
              <surname>Ras</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>The number of people with a mild intellectual disability: an estimate</article-title>
          <source>Sociaal en Cultureel Planbureau</source>
          <access-date>2024-10-15</access-date>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://www.scp.nl/publicaties/publicaties/2019/10/01/het-aantal-mensen-met-een-licht-verstandelijke-beperking-een-schatting">https://www.scp.nl/publicaties/publicaties/2019/10/01/het-aantal-mensen-met-een-licht-verstandelijke-beperking-een-schatting</ext-link>
          </comment>
        </nlm-citation>
      </ref>
      <ref id="ref6">
        <label>6</label>
        <nlm-citation citation-type="web">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Videler</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Heijnen-Kohl</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Wilting</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Autismestoornissen bij ouderen</article-title>
          <source>Trimbos</source>
          <access-date>2024-10-15</access-date>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://www.trimbos.nl/kennis/ouderenpsychiatrie-nkop/autisme-ouderen/">https://www.trimbos.nl/kennis/ouderenpsychiatrie-nkop/autisme-ouderen/</ext-link>
          </comment>
        </nlm-citation>
      </ref>
      <ref id="ref7">
        <label>7</label>
        <nlm-citation citation-type="web">
          <article-title>De gehandicaptenzorg in kerngetallen</article-title>
          <source>Vereniging Gehandicaptenzorg Nederland</source>
          <access-date>2024-10-15</access-date>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://www.vgn.nl/system/files/2019-09/VGN_infographic_300919_DEF.pdf">https://www.vgn.nl/system/files/2019-09/VGN_infographic_300919_DEF.pdf</ext-link>
          </comment>
        </nlm-citation>
      </ref>
      <ref id="ref8">
        <label>8</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Rosenblum</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Sharfi</surname>
              <given-names>K</given-names>
            </name>
            <name name-style="western">
              <surname>Elimelech</surname>
              <given-names>OC</given-names>
            </name>
            <name name-style="western">
              <surname>Regev</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Grinblat</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Predicting emotional consequences of disorganization among adults with neurodevelopmental disorders: a structural equation model</article-title>
          <source>Disabil Rehabil</source>
          <year>2025</year>
          <month>04</month>
          <volume>47</volume>
          <issue>8</issue>
          <fpage>1954</fpage>
          <lpage>64</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://www.tandfonline.com/doi/abs/10.1080/09638288.2024.2385733?url_ver=Z39.88-2003&#38;rfr_id=ori:rid:crossref.org&#38;rfr_dat=cr_pub  0pubmed"/>
          </comment>
          <pub-id pub-id-type="doi">10.1080/09638288.2024.2385733</pub-id>
          <pub-id pub-id-type="medline">39119890</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref9">
        <label>9</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Desideri</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Lancioni</surname>
              <given-names>G</given-names>
            </name>
            <name name-style="western">
              <surname>Malavasi</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Gherardini</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Cesario</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Step-instruction technology to help people with intellectual and other disabilities perform multistep tasks: a literature review</article-title>
          <source>J Dev Phys Disabil</source>
          <year>2020</year>
          <month>11</month>
          <day>17</day>
          <volume>33</volume>
          <fpage>857</fpage>
          <lpage>86</lpage>
          <pub-id pub-id-type="doi">10.1007/s10882-020-09781-7</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref10">
        <label>10</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>van Dam</surname>
              <given-names>K</given-names>
            </name>
            <name name-style="western">
              <surname>Gielissen</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Bles</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>van der Poel</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Boon</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>The impact of assistive living technology on perceived independence of people with a physical disability in executing daily activities: a systematic literature review</article-title>
          <source>Disabil Rehabil Assist Technol</source>
          <year>2024</year>
          <month>05</month>
          <volume>19</volume>
          <issue>4</issue>
          <fpage>1262</fpage>
          <lpage>71</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://www.tandfonline.com/doi/abs/10.1080/17483107.2022.2162614?url_ver=Z39.88-2003&#38;rfr_id=ori:rid:crossref.org&#38;rfr_dat=cr_pub  0pubmed"/>
          </comment>
          <pub-id pub-id-type="doi">10.1080/17483107.2022.2162614</pub-id>
          <pub-id pub-id-type="medline">36628433</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref11">
        <label>11</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Stierle</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Ryan</surname>
              <given-names>JB</given-names>
            </name>
            <name name-style="western">
              <surname>Katsiyannis</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Mims</surname>
              <given-names>P</given-names>
            </name>
            <name name-style="western">
              <surname>Carlson</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Allen</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Using smart phone technology to improve daily living skills for individuals with intellectual disabilities</article-title>
          <source>J Appl Res Intellect Disabil</source>
          <year>2023</year>
          <month>09</month>
          <volume>36</volume>
          <issue>5</issue>
          <fpage>1169</fpage>
          <lpage>78</lpage>
          <pub-id pub-id-type="doi">10.1111/jar.13139</pub-id>
          <pub-id pub-id-type="medline">37417242</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref12">
        <label>12</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Gillespie</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Best</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>O'Neill</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Cognitive function and assistive technology for cognition: a systematic review</article-title>
          <source>J Int Neuropsychol Soc</source>
          <year>2012</year>
          <month>01</month>
          <volume>18</volume>
          <issue>1</issue>
          <fpage>1</fpage>
          <lpage>19</lpage>
          <pub-id pub-id-type="doi">10.1017/S1355617711001548</pub-id>
          <pub-id pub-id-type="medline">22152338</pub-id>
          <pub-id pub-id-type="pii">S1355617711001548</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref13">
        <label>13</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Brandt</surname>
              <given-names>Å</given-names>
            </name>
            <name name-style="western">
              <surname>Jensen</surname>
              <given-names>MP</given-names>
            </name>
            <name name-style="western">
              <surname>Søberg</surname>
              <given-names>MS</given-names>
            </name>
            <name name-style="western">
              <surname>Andersen</surname>
              <given-names>SD</given-names>
            </name>
            <name name-style="western">
              <surname>Sund</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Information and communication technology-based assistive technology to compensate for impaired cognition in everyday life: a systematic review</article-title>
          <source>Disabil Rehabil Assist Technol</source>
          <year>2020</year>
          <month>10</month>
          <volume>15</volume>
          <issue>7</issue>
          <fpage>810</fpage>
          <lpage>24</lpage>
          <pub-id pub-id-type="doi">10.1080/17483107.2020.1765032</pub-id>
          <pub-id pub-id-type="medline">32407217</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref14">
        <label>14</label>
        <nlm-citation citation-type="web">
          <article-title>Toekomstbestendige zorg en ondersteuning voor mensen met een beperking</article-title>
          <source>Rijksinstituut voor Volksgezondheid en Milieu</source>
          <access-date>2024-10-22</access-date>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://www.rivm.nl/publicaties/toekomstbestendige-zorg-en-ondersteuning-voor-mensen-met-beperking-plan-van-aanpak-voor">https://www.rivm.nl/publicaties/toekomstbestendige-zorg-en-ondersteuning-voor-mensen-met-beperking-plan-van-aanpak-voor</ext-link>
          </comment>
        </nlm-citation>
      </ref>
      <ref id="ref15">
        <label>15</label>
        <nlm-citation citation-type="book">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Gartlehner</surname>
              <given-names>G</given-names>
            </name>
            <name name-style="western">
              <surname>Hansen</surname>
              <given-names>RA</given-names>
            </name>
            <name name-style="western">
              <surname>Nissman</surname>
              <given-names>D</given-names>
            </name>
            <name name-style="western">
              <surname>Lohr</surname>
              <given-names>KN</given-names>
            </name>
            <name name-style="western">
              <surname>Carey</surname>
              <given-names>TS</given-names>
            </name>
          </person-group>
          <source>Criteria for Distinguishing Effectiveness From Efficacy Trials in Systematic Reviews</source>
          <year>2006</year>
          <publisher-loc>Rockville, MD</publisher-loc>
          <publisher-name>Agency for Healthcare Research and Quality</publisher-name>
        </nlm-citation>
      </ref>
      <ref id="ref16">
        <label>16</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Aral</surname>
              <given-names>SO</given-names>
            </name>
            <name name-style="western">
              <surname>Peterman</surname>
              <given-names>TA</given-names>
            </name>
          </person-group>
          <article-title>Do we know the effectiveness of behavioural interventions?</article-title>
          <source>Lancet</source>
          <year>1998</year>
          <volume>351 Suppl 3</volume>
          <fpage>33</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="doi">10.1016/s0140-6736(98)90010-1</pub-id>
          <pub-id pub-id-type="medline">9652720</pub-id>
          <pub-id pub-id-type="pii">S0140-6736(98)90010-1</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref17">
        <label>17</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>van Dam</surname>
              <given-names>K</given-names>
            </name>
            <name name-style="western">
              <surname>Gielissen</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Reijnders</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>van der Poel</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Boon</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Experiences of persons with executive dysfunction in disability care using a social robot to execute daily tasks and increase the feeling of independence: multiple-case study</article-title>
          <source>JMIR Rehabil Assist Technol</source>
          <year>2022</year>
          <month>11</month>
          <day>03</day>
          <volume>9</volume>
          <issue>4</issue>
          <fpage>e41313</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://rehab.jmir.org/2022/4/e41313/"/>
          </comment>
          <pub-id pub-id-type="doi">10.2196/41313</pub-id>
          <pub-id pub-id-type="medline">36326800</pub-id>
          <pub-id pub-id-type="pii">v9i4e41313</pub-id>
          <pub-id pub-id-type="pmcid">PMC9672999</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref18">
        <label>18</label>
        <nlm-citation citation-type="web">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Bierhoff</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>Welke technologie gebruiken organisaties in de gehandicaptenzorg bij de zorg en ondersteuning van hun cliënten en medewerkers? Resultaten uit inventarisatie 2023</article-title>
          <source>Branchevereniging Kleinschalige Zorg</source>
          <year>2024</year>
          <month>07</month>
          <access-date>2025-07-10</access-date>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://bvkz.nl/wp-content/uploads/2024/09/Publicatie-Technologie-in-gebruik_versie-juli-2024.pdf">https://bvkz.nl/wp-content/uploads/2024/09/Publicatie-Technologie-in-gebruik_versie-juli-2024.pdf</ext-link>
          </comment>
        </nlm-citation>
      </ref>
      <ref id="ref19">
        <label>19</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Chan</surname>
              <given-names>AW</given-names>
            </name>
            <name name-style="western">
              <surname>Tetzlaff</surname>
              <given-names>JM</given-names>
            </name>
            <name name-style="western">
              <surname>Altman</surname>
              <given-names>DG</given-names>
            </name>
            <name name-style="western">
              <surname>Laupacis</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Gøtzsche</surname>
              <given-names>PC</given-names>
            </name>
            <name name-style="western">
              <surname>Krleža-Jerić</surname>
              <given-names>K</given-names>
            </name>
            <name name-style="western">
              <surname>Hróbjartsson</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Mann</surname>
              <given-names>H</given-names>
            </name>
            <name name-style="western">
              <surname>Dickersin</surname>
              <given-names>K</given-names>
            </name>
            <name name-style="western">
              <surname>Berlin</surname>
              <given-names>JA</given-names>
            </name>
            <name name-style="western">
              <surname>Doré</surname>
              <given-names>CJ</given-names>
            </name>
            <name name-style="western">
              <surname>Parulekar</surname>
              <given-names>WR</given-names>
            </name>
            <name name-style="western">
              <surname>Summerskill</surname>
              <given-names>WS</given-names>
            </name>
            <name name-style="western">
              <surname>Groves</surname>
              <given-names>T</given-names>
            </name>
            <name name-style="western">
              <surname>Schulz</surname>
              <given-names>KF</given-names>
            </name>
            <name name-style="western">
              <surname>Sox</surname>
              <given-names>HC</given-names>
            </name>
            <name name-style="western">
              <surname>Rockhold</surname>
              <given-names>FW</given-names>
            </name>
            <name name-style="western">
              <surname>Rennie</surname>
              <given-names>D</given-names>
            </name>
            <name name-style="western">
              <surname>Moher</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>SPIRIT 2013 statement: defining standard protocol items for clinical trials</article-title>
          <source>Ann Intern Med</source>
          <year>2013</year>
          <month>02</month>
          <day>05</day>
          <volume>158</volume>
          <issue>3</issue>
          <fpage>200</fpage>
          <lpage>7</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://www.acpjournals.org/doi/abs/10.7326/0003-4819-158-3-201302050-00583?url_ver=Z39.88-2003&#38;rfr_id=ori:rid:crossref.org&#38;rfr_dat=cr_pub  0pubmed"/>
          </comment>
          <pub-id pub-id-type="doi">10.7326/0003-4819-158-3-201302050-00583</pub-id>
          <pub-id pub-id-type="medline">23295957</pub-id>
          <pub-id pub-id-type="pii">1556168</pub-id>
          <pub-id pub-id-type="pmcid">PMC5114123</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref20">
        <label>20</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Epstein</surname>
              <given-names>LH</given-names>
            </name>
            <name name-style="western">
              <surname>Dallery</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>The family of single-case experimental designs</article-title>
          <source>Harv Data Sci Rev</source>
          <year>2022</year>
          <volume>4</volume>
          <issue>SI3</issue>
          <fpage>10.1162/99608f92.ff9300a8</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://europepmc.org/abstract/MED/36926648"/>
          </comment>
          <pub-id pub-id-type="doi">10.1162/99608f92.ff9300a8</pub-id>
          <pub-id pub-id-type="medline">36926648</pub-id>
          <pub-id pub-id-type="pmcid">PMC10016625</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref21">
        <label>21</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Wilson</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Rooshenas</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Paramasivan</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Elliott</surname>
              <given-names>D</given-names>
            </name>
            <name name-style="western">
              <surname>Jepson</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Strong</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Birtle</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Beard</surname>
              <given-names>DJ</given-names>
            </name>
            <name name-style="western">
              <surname>Halliday</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Hamdy</surname>
              <given-names>FC</given-names>
            </name>
            <name name-style="western">
              <surname>Lewis</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Metcalfe</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Rogers</surname>
              <given-names>CA</given-names>
            </name>
            <name name-style="western">
              <surname>Stein</surname>
              <given-names>RC</given-names>
            </name>
            <name name-style="western">
              <surname>Blazeby</surname>
              <given-names>JM</given-names>
            </name>
            <name name-style="western">
              <surname>Donovan</surname>
              <given-names>JL</given-names>
            </name>
          </person-group>
          <article-title>Development of a framework to improve the process of recruitment to randomised controlled trials (RCTs): the SEAR (Screened, Eligible, Approached, Randomised) framework</article-title>
          <source>Trials</source>
          <year>2018</year>
          <month>01</month>
          <day>19</day>
          <volume>19</volume>
          <issue>1</issue>
          <fpage>50</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-017-2413-6"/>
          </comment>
          <pub-id pub-id-type="doi">10.1186/s13063-017-2413-6</pub-id>
          <pub-id pub-id-type="medline">29351790</pub-id>
          <pub-id pub-id-type="pii">10.1186/s13063-017-2413-6</pub-id>
          <pub-id pub-id-type="pmcid">PMC5775609</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref22">
        <label>22</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Vohra</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Shamseer</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Sampson</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Bukutu</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Schmid</surname>
              <given-names>CH</given-names>
            </name>
            <name name-style="western">
              <surname>Tate</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Nikles</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Zucker</surname>
              <given-names>DR</given-names>
            </name>
            <name name-style="western">
              <surname>Kravitz</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Guyatt</surname>
              <given-names>G</given-names>
            </name>
            <name name-style="western">
              <surname>Altman</surname>
              <given-names>DG</given-names>
            </name>
            <name name-style="western">
              <surname>Moher</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>CONSORT extension for reporting N-of-1 trials (CENT) 2015 statement</article-title>
          <source>BMJ</source>
          <year>2015</year>
          <month>05</month>
          <day>14</day>
          <volume>350</volume>
          <fpage>h1738</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://www.bmj.com/lookup/pmidlookup?view=long&#38;pmid=25976398"/>
          </comment>
          <pub-id pub-id-type="doi">10.1136/bmj.h1738</pub-id>
          <pub-id pub-id-type="medline">25976398</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref23">
        <label>23</label>
        <nlm-citation citation-type="web">
          <source>TinyBots</source>
          <access-date>2025-07-12</access-date>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://tinybots.nl/">https://tinybots.nl/</ext-link>
          </comment>
        </nlm-citation>
      </ref>
      <ref id="ref24">
        <label>24</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Kiresuk</surname>
              <given-names>TJ</given-names>
            </name>
            <name name-style="western">
              <surname>Sherman</surname>
              <given-names>RE</given-names>
            </name>
          </person-group>
          <article-title>Goal attainment scaling: a general method for evaluating comprehensive community mental health programs</article-title>
          <source>Community Ment Health J</source>
          <year>1968</year>
          <month>12</month>
          <volume>4</volume>
          <issue>6</issue>
          <fpage>443</fpage>
          <lpage>53</lpage>
          <pub-id pub-id-type="doi">10.1007/BF01530764</pub-id>
          <pub-id pub-id-type="medline">24185570</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref25">
        <label>25</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Krasny-Pacini</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Evans</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Sohlberg</surname>
              <given-names>MM</given-names>
            </name>
            <name name-style="western">
              <surname>Chevignard</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Proposed criteria for appraising goal attainment scales used as outcome measures in rehabilitation research</article-title>
          <source>Arch Phys Med Rehabil</source>
          <year>2016</year>
          <month>01</month>
          <volume>97</volume>
          <issue>1</issue>
          <fpage>157</fpage>
          <lpage>70</lpage>
          <pub-id pub-id-type="doi">10.1016/j.apmr.2015.08.424</pub-id>
          <pub-id pub-id-type="medline">26343173</pub-id>
          <pub-id pub-id-type="pii">S0003-9993(15)01151-X</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref26">
        <label>26</label>
        <nlm-citation citation-type="book">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Cummins</surname>
              <given-names>RA</given-names>
            </name>
            <name name-style="western">
              <surname>Lau</surname>
              <given-names>AL</given-names>
            </name>
            <name name-style="western">
              <surname>Davey</surname>
              <given-names>G</given-names>
            </name>
            <name name-style="western">
              <surname>McGillivray</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name name-style="western">
              <surname>Kober</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Measuring subjective wellbeing: the personal wellbeing index – intellectual disability</article-title>
          <source>Enhancing the Quality of Life of People with Intellectual Disabilities</source>
          <year>2010</year>
          <publisher-loc>Dordrecht, The Netherlands</publisher-loc>
          <publisher-name>Springer</publisher-name>
        </nlm-citation>
      </ref>
      <ref id="ref27">
        <label>27</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Atigossou</surname>
              <given-names>OL</given-names>
            </name>
            <name name-style="western">
              <surname>Honado</surname>
              <given-names>AS</given-names>
            </name>
            <name name-style="western">
              <surname>Routhier</surname>
              <given-names>F</given-names>
            </name>
            <name name-style="western">
              <surname>Flamand</surname>
              <given-names>VH</given-names>
            </name>
          </person-group>
          <article-title>Psychometric properties of the psychosocial impact of assistive devices scale (PIADS): a systematic review</article-title>
          <source>Assist Technol</source>
          <year>2023</year>
          <month>05</month>
          <day>04</day>
          <volume>35</volume>
          <issue>3</issue>
          <fpage>211</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1080/10400435.2021.2010149</pub-id>
          <pub-id pub-id-type="medline">34813722</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref28">
        <label>28</label>
        <nlm-citation citation-type="web">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Bouwmans</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Hakkaart- van Roijen</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Koopmanschap</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Krol</surname>
              <given-names>M</given-names>
            </name>
            <collab>Severens</collab>
            <name name-style="western">
              <surname>Brouwer</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>iMTA medical consumption questionnaire</article-title>
          <source>Erasmus University</source>
          <year>2012</year>
          <month>10</month>
          <access-date>2025-07-10</access-date>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://projecten.zonmw.nl/sites/zonmw/files/typo3-migrated-files/Handleiding_MCQ_oktober_2012_draft_versie_1.pdf">https://projecten.zonmw.nl/sites/zonmw/files/typo3-migrated-files/Handleiding_MCQ_oktober_2012_draft_versie_1.pdf</ext-link>
          </comment>
        </nlm-citation>
      </ref>
      <ref id="ref29">
        <label>29</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Bouwmans</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Krol</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Brouwer</surname>
              <given-names>W</given-names>
            </name>
            <name name-style="western">
              <surname>Severens</surname>
              <given-names>JL</given-names>
            </name>
            <name name-style="western">
              <surname>Koopmanschap</surname>
              <given-names>MA</given-names>
            </name>
            <name name-style="western">
              <surname>Hakkaart</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>IMTA Productivity Cost Questionnaire (IPCQ)</article-title>
          <source>Value Health</source>
          <year>2014</year>
          <month>11</month>
          <volume>17</volume>
          <issue>7</issue>
          <fpage>A550</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://linkinghub.elsevier.com/retrieve/pii/S1098-3015(14)03721-8"/>
          </comment>
          <pub-id pub-id-type="doi">10.1016/j.jval.2014.08.1791</pub-id>
          <pub-id pub-id-type="medline">27201788</pub-id>
          <pub-id pub-id-type="pii">S1098-3015(14)03721-8</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref30">
        <label>30</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Al-Janabi</surname>
              <given-names>H</given-names>
            </name>
            <name name-style="western">
              <surname>Flynn</surname>
              <given-names>TN</given-names>
            </name>
            <name name-style="western">
              <surname>Coast</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Development of a self-report measure of capability wellbeing for adults: the ICECAP-A</article-title>
          <source>Qual Life Res</source>
          <year>2012</year>
          <month>03</month>
          <volume>21</volume>
          <issue>1</issue>
          <fpage>167</fpage>
          <lpage>76</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://europepmc.org/abstract/MED/21598064"/>
          </comment>
          <pub-id pub-id-type="doi">10.1007/s11136-011-9927-2</pub-id>
          <pub-id pub-id-type="medline">21598064</pub-id>
          <pub-id pub-id-type="pmcid">PMC3254872</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref31">
        <label>31</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>van Hoof</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Jeuring</surname>
              <given-names>SF</given-names>
            </name>
            <name name-style="western">
              <surname>Jonkers</surname>
              <given-names>DM</given-names>
            </name>
            <name name-style="western">
              <surname>Masclee</surname>
              <given-names>AA</given-names>
            </name>
            <name name-style="western">
              <surname>Pierik</surname>
              <given-names>MJ</given-names>
            </name>
            <name name-style="western">
              <surname>Stokroos</surname>
              <given-names>RJ</given-names>
            </name>
            <name name-style="western">
              <surname>Joore</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>De Nederlandse vertaling en indruksvalidatie van de ICECAP-A: meten van kwaliteit van leven volgens de capability-benadering</article-title>
          <source>Tijdschr Gezondheidswet</source>
          <year>2016</year>
          <month>12</month>
          <day>23</day>
          <volume>94</volume>
          <fpage>313</fpage>
          <lpage>20</lpage>
          <pub-id pub-id-type="doi">10.1007/s12508-016-0109-z</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref32">
        <label>32</label>
        <nlm-citation citation-type="web">
          <article-title>Richtlijn voor het uitvoeren van economische evaluaties in de gezondheidszorg (versie 2024)</article-title>
          <source>Zorginstituut Nederland</source>
          <year>2024</year>
          <access-date>2025-07-10</access-date>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://www.zorginstituutnederland.nl/publicaties/publicatie/2024/01/16/richtlijn-voor-het-uitvoeren-van-economische-evaluaties-in-de-gezondheidszorg">https://www.zorginstituutnederland.nl/publicaties/publicatie/2024/01/16/richtlijn-voor-het-uitvoeren-van-economische-evaluaties-in-de-gezondheidszorg</ext-link>
          </comment>
        </nlm-citation>
      </ref>
      <ref id="ref33">
        <label>33</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Goldfeld</surname>
              <given-names>K</given-names>
            </name>
            <name name-style="western">
              <surname>Wujciak-Jens</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>simstudy: illuminating research methods through data generation</article-title>
          <source>J Open Source Softw</source>
          <year>2020</year>
          <month>10</month>
          <volume>5</volume>
          <issue>54</issue>
          <fpage>2763</fpage>
          <pub-id pub-id-type="doi">10.21105/joss.02763</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref34">
        <label>34</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Schafer</surname>
              <given-names>JL</given-names>
            </name>
            <name name-style="western">
              <surname>Graham</surname>
              <given-names>JW</given-names>
            </name>
          </person-group>
          <article-title>Missing data: our view of the state of the art</article-title>
          <source>Psychol Methods</source>
          <year>2002</year>
          <month>06</month>
          <volume>7</volume>
          <issue>2</issue>
          <fpage>147</fpage>
          <lpage>77</lpage>
          <pub-id pub-id-type="medline">12090408</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref35">
        <label>35</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Jacobson</surname>
              <given-names>NS</given-names>
            </name>
            <name name-style="western">
              <surname>Truax</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Clinical significance: a statistical approach to defining meaningful change in psychotherapy research</article-title>
          <source>J Consult Clin Psychol</source>
          <year>1991</year>
          <month>02</month>
          <volume>59</volume>
          <issue>1</issue>
          <fpage>12</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1037//0022-006x.59.1.12</pub-id>
          <pub-id pub-id-type="medline">2002127</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref36">
        <label>36</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Kratochwill</surname>
              <given-names>TR</given-names>
            </name>
            <name name-style="western">
              <surname>Horner</surname>
              <given-names>RH</given-names>
            </name>
            <name name-style="western">
              <surname>Levin</surname>
              <given-names>JR</given-names>
            </name>
            <name name-style="western">
              <surname>Machalicek</surname>
              <given-names>W</given-names>
            </name>
            <name name-style="western">
              <surname>Ferron</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Johnson</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Single-case intervention research design standards: additional proposed upgrades and future directions</article-title>
          <source>J Sch Psychol</source>
          <year>2023</year>
          <month>04</month>
          <volume>97</volume>
          <fpage>192</fpage>
          <lpage>216</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jsp.2022.12.002</pub-id>
          <pub-id pub-id-type="medline">36914365</pub-id>
          <pub-id pub-id-type="pii">S0022-4405(22)00096-6</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref37">
        <label>37</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Husereau</surname>
              <given-names>D</given-names>
            </name>
            <name name-style="western">
              <surname>Drummond</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Augustovski</surname>
              <given-names>F</given-names>
            </name>
            <name name-style="western">
              <surname>de Bekker-Grob</surname>
              <given-names>E</given-names>
            </name>
            <name name-style="western">
              <surname>Briggs</surname>
              <given-names>AH</given-names>
            </name>
            <name name-style="western">
              <surname>Carswell</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Caulley</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Chaiyakunapruk</surname>
              <given-names>N</given-names>
            </name>
            <name name-style="western">
              <surname>Greenberg</surname>
              <given-names>D</given-names>
            </name>
            <name name-style="western">
              <surname>Loder</surname>
              <given-names>E</given-names>
            </name>
            <name name-style="western">
              <surname>Mauskopf</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Mullins</surname>
              <given-names>CD</given-names>
            </name>
            <name name-style="western">
              <surname>Petrou</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Pwu</surname>
              <given-names>RF</given-names>
            </name>
            <name name-style="western">
              <surname>Staniszewska</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Consolidated health economic evaluation reporting standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations</article-title>
          <source>Value Health</source>
          <year>2022</year>
          <month>01</month>
          <volume>25</volume>
          <issue>1</issue>
          <fpage>3</fpage>
          <lpage>9</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://linkinghub.elsevier.com/retrieve/pii/S1098-3015(21)03146-6"/>
          </comment>
          <pub-id pub-id-type="doi">10.1016/j.jval.2021.11.1351</pub-id>
          <pub-id pub-id-type="medline">35031096</pub-id>
          <pub-id pub-id-type="pii">S1098-3015(21)03146-6</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref38">
        <label>38</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Caro</surname>
              <given-names>JJ</given-names>
            </name>
            <name name-style="western">
              <surname>Briggs</surname>
              <given-names>AH</given-names>
            </name>
            <name name-style="western">
              <surname>Siebert</surname>
              <given-names>U</given-names>
            </name>
            <name name-style="western">
              <surname>Kuntz</surname>
              <given-names>KM</given-names>
            </name>
            <collab>ISPOR-SMDM Modeling Good Research Practices Task Force</collab>
          </person-group>
          <article-title>Modeling good research practices--overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1</article-title>
          <source>Med Decis Making</source>
          <year>2012</year>
          <volume>32</volume>
          <issue>5</issue>
          <fpage>667</fpage>
          <lpage>77</lpage>
          <pub-id pub-id-type="doi">10.1177/0272989X12454577</pub-id>
          <pub-id pub-id-type="medline">22990082</pub-id>
          <pub-id pub-id-type="pii">32/5/667</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref39">
        <label>39</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Rohrbach</surname>
              <given-names>PJ</given-names>
            </name>
            <name name-style="western">
              <surname>Dingemans</surname>
              <given-names>AE</given-names>
            </name>
            <name name-style="western">
              <surname>Essers</surname>
              <given-names>BA</given-names>
            </name>
            <name name-style="western">
              <surname>Van Furth</surname>
              <given-names>EF</given-names>
            </name>
            <name name-style="western">
              <surname>Spinhoven</surname>
              <given-names>P</given-names>
            </name>
            <name name-style="western">
              <surname>Groothuis-Oudshoorn</surname>
              <given-names>CG</given-names>
            </name>
            <name name-style="western">
              <surname>Van Til</surname>
              <given-names>JA</given-names>
            </name>
            <name name-style="western">
              <surname>Van den Akker-Van Marle</surname>
              <given-names>ME</given-names>
            </name>
          </person-group>
          <article-title>The ICECAP-A instrument for capabilities: assessment of construct validity and test-retest reliability in a general Dutch population</article-title>
          <source>Qual Life Res</source>
          <year>2022</year>
          <month>03</month>
          <volume>31</volume>
          <issue>3</issue>
          <fpage>687</fpage>
          <lpage>96</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://europepmc.org/abstract/MED/34463861"/>
          </comment>
          <pub-id pub-id-type="doi">10.1007/s11136-021-02980-5</pub-id>
          <pub-id pub-id-type="medline">34463861</pub-id>
          <pub-id pub-id-type="pii">10.1007/s11136-021-02980-5</pub-id>
          <pub-id pub-id-type="pmcid">PMC8921020</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref40">
        <label>40</label>
        <nlm-citation citation-type="web">
          <article-title>Zinnige en duurzame zorg</article-title>
          <source>Raad voor Volksgezondheid &#38; Samenleving</source>
          <access-date>2025-07-10</access-date>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://www.raadrvs.nl/documenten/publicaties/2006/06/07/zinnige-en-duurzame-zorg">https://www.raadrvs.nl/documenten/publicaties/2006/06/07/zinnige-en-duurzame-zorg</ext-link>
          </comment>
        </nlm-citation>
      </ref>
      <ref id="ref41">
        <label>41</label>
        <nlm-citation citation-type="book">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Kratochwill</surname>
              <given-names>TR</given-names>
            </name>
            <name name-style="western">
              <surname>Levin</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <source>Single-Case Intervention Research: Methodological and Statistical Advances</source>
          <year>2014</year>
          <publisher-loc>Washington, DC</publisher-loc>
          <publisher-name>American Psychological Association</publisher-name>
        </nlm-citation>
      </ref>
      <ref id="ref42">
        <label>42</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Levin</surname>
              <given-names>JR</given-names>
            </name>
            <name name-style="western">
              <surname>Ferron</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Different randomized multiple-baseline models for different situations: a practical guide for single-case intervention researchers</article-title>
          <source>J Sch Psychol</source>
          <year>2021</year>
          <month>06</month>
          <volume>86</volume>
          <fpage>169</fpage>
          <lpage>77</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jsp.2021.03.003</pub-id>
          <pub-id pub-id-type="medline">34051912</pub-id>
          <pub-id pub-id-type="pii">S0022-4405(21)00026-1</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref43">
        <label>43</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Byiers</surname>
              <given-names>BJ</given-names>
            </name>
            <name name-style="western">
              <surname>Reichle</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Symons</surname>
              <given-names>FJ</given-names>
            </name>
          </person-group>
          <article-title>Single-subject experimental design for evidence-based practice</article-title>
          <source>Am J Speech Lang Pathol</source>
          <year>2012</year>
          <month>11</month>
          <volume>21</volume>
          <issue>4</issue>
          <fpage>397</fpage>
          <lpage>414</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://europepmc.org/abstract/MED/23071200"/>
          </comment>
          <pub-id pub-id-type="doi">10.1044/1058-0360(2012/11-0036)</pub-id>
          <pub-id pub-id-type="medline">23071200</pub-id>
          <pub-id pub-id-type="pii">1058-0360_2012_11-0036</pub-id>
          <pub-id pub-id-type="pmcid">PMC3992321</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref44">
        <label>44</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Tanious</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Onghena</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Randomized single-case experimental designs in healthcare research: what, why, and how?</article-title>
          <source>Healthcare (Basel)</source>
          <year>2019</year>
          <month>11</month>
          <day>13</day>
          <volume>7</volume>
          <issue>4</issue>
          <fpage>143</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://www.mdpi.com/resolver?pii=healthcare7040143"/>
          </comment>
          <pub-id pub-id-type="doi">10.3390/healthcare7040143</pub-id>
          <pub-id pub-id-type="medline">31766188</pub-id>
          <pub-id pub-id-type="pii">healthcare7040143</pub-id>
          <pub-id pub-id-type="pmcid">PMC6955662</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref45">
        <label>45</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Vohra</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>N-of-1 trials to enhance patient outcomes: identifying effective therapies and reducing harms, one patient at a time</article-title>
          <source>J Clin Epidemiol</source>
          <year>2016</year>
          <month>08</month>
          <volume>76</volume>
          <fpage>6</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jclinepi.2016.03.028</pub-id>
          <pub-id pub-id-type="medline">27134139</pub-id>
          <pub-id pub-id-type="pii">S0895-4356(16)30089-0</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref46">
        <label>46</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Lobo</surname>
              <given-names>MA</given-names>
            </name>
            <name name-style="western">
              <surname>Moeyaert</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Baraldi Cunha</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Babik</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>Single-case design, analysis, and quality assessment for intervention research</article-title>
          <source>J Neurol Phys Ther</source>
          <year>2017</year>
          <month>07</month>
          <volume>41</volume>
          <issue>3</issue>
          <fpage>187</fpage>
          <lpage>97</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://europepmc.org/abstract/MED/28628553"/>
          </comment>
          <pub-id pub-id-type="doi">10.1097/NPT.0000000000000187</pub-id>
          <pub-id pub-id-type="medline">28628553</pub-id>
          <pub-id pub-id-type="pii">01253086-201707000-00007</pub-id>
          <pub-id pub-id-type="pmcid">PMC5492992</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref47">
        <label>47</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Krasny-Pacini</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Evans</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Single-case experimental designs to assess intervention effectiveness in rehabilitation: a practical guide</article-title>
          <source>Ann Phys Rehabil Med</source>
          <year>2018</year>
          <month>05</month>
          <volume>61</volume>
          <issue>3</issue>
          <fpage>164</fpage>
          <lpage>79</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://linkinghub.elsevier.com/retrieve/pii/S1877-0657(17)30454-2"/>
          </comment>
          <pub-id pub-id-type="doi">10.1016/j.rehab.2017.12.002</pub-id>
          <pub-id pub-id-type="medline">29253607</pub-id>
          <pub-id pub-id-type="pii">S1877-0657(17)30454-2</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref48">
        <label>48</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Di Lorito</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Bosco</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Birt</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Hassiotis</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Co-research with adults with intellectual disability: a systematic review</article-title>
          <source>J Appl Res Intellect Disabil</source>
          <year>2018</year>
          <month>09</month>
          <volume>31</volume>
          <issue>5</issue>
          <fpage>669</fpage>
          <lpage>86</lpage>
          <pub-id pub-id-type="doi">10.1111/jar.12435</pub-id>
          <pub-id pub-id-type="medline">29231285</pub-id>
        </nlm-citation>
      </ref>
    </ref-list>
  </back>
</article>
